Co-Administration of Amiodarone Increases Bleeding by Affecting Rivaroxaban Pharmacokinetics in Patients with Atrial Fibrillation

This study aimed to investigate the impact of the drug–drug interaction between rivaroxaban and amiodarone on the clinical outcomes in patients with non-valvular atrial fibrillation (NVAF), focusing on pharmacokinetic and pharmacodynamic (PK/PD) aspects. A prospective study enrolling 174 patients wi...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Huamin Ding, Zi Wang, Jia Wang, Yao Yao, Chi Zhang, Houwen Lin, Yong Zhou, Zhichun Gu, Qianzhou Lv, Xiaoye Li
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2024-07-01
Colecção:	Pharmaceutics
Assuntos:	rivaroxaban amiodarone DDI PK/PD bleeding events
Acesso em linha:	https://www.mdpi.com/1999-4923/16/8/1006
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!